Interesting information, but what does this have to do with Pluristem? Do they share the same 3D reactor technology? Is Pluristem's 3D bioreactor technology/patents fully owned by PSTI, or partially owned by Meretzki? Assume that Bonus Biogroup's fortunes are not relevant to PSTI...
Wouldn't increasing ownership show up in required SEC documentation for positions, insider, at 5%? 5% is nowhere near significant enough for takeover leverage..
Is there a research report on this company? What is the value of additional State approvals (NJ,CA,IL, TX,Fl. etc.)as they are received, and what will it take to get the HMO's etc. to approve...what should revenues be in 3 years, and how should the Market Cap follow? Market Cap at low $35M approx., but current sales are miniscule. How should sales be modeled, realistically. This picture is a black hole...no wonder it is still at approx $3. My thinking is that it only moves when they get national health organizations to insure the use.
From the CC it appears that CDXS is working to transition the offloaded technologies/staff to DYAI, perhaps in exchange for expunging possible future litigation/penalties, and maybe along with a royalty carrot? I would imagine they'll have their deal completed by year-end? Would benefit both companies. Goes back to DYAI controlling this situation with their patents.
Looks like the start-up will be further into Q1 than Q4. There are 13 job postings for the Kansas facility that just went up last week. By the time personnel are found, interviewed, hired, re-located to the site, I would imagine it will be February before the facility only starts to work out its kinks. Maybe Q2 they become a fully functioning facility.
Biggest and Best in the WORLD sees the potential of investing in and spearheading market penetration and new product development of CDXC. This is the opportunity that was worth waiting for. We will be bought out at 5-10 times current price in 3 years or less. I can wait.
can't post link on Yahoo. USEL board also id' John Ford, SA author taking position in USEL yesterday. John has written up OPKO, MSLP and others before they tripled. Smart guy who believes in Frost investmentsl
Just made aware of Forbes article, 10/11/13, author, Richard Finger, which identified P.Frost as significant investor in USEL. Noticed in the Yaho0 filing that Frost associates are listed as insiders.
Please learn the difference between your and you're before you post. Shows your lack of basic education. No one should listen to someone with 2nd grade thinking skills. You are on ignore.